Investigators found that protein lysine methyltransferase G9A was overexpressed in chronic myelogenous leukemia leukemia stem cells.
[Oncogene]
6807162 NHFQED8T items 1 apa 0 default asc 1 161776 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-d6c94ec396ee96ecf181bd57dc1a5b39%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22NHFQED8T%22%2C%22library%22%3A%7B%22id%22%3A6807162%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Zhou%20et%20al.%22%2C%22parsedDate%22%3A%222021-04-30%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EZhou%2C%20M.%2C%20Zhang%2C%20X.%2C%20Liu%2C%20C.%2C%20Nie%2C%20D.%2C%20Li%2C%20S.%2C%20Lai%2C%20P.%2C%20%26amp%3B%20Jin%2C%20Y.%20%282021%29.%20Targeting%20protein%20lysine%20methyltransferase%20G9A%20impairs%20self-renewal%20of%20chronic%20myelogenous%20leukemia%20stem%20cells%20via%20upregulation%20of%20SOX6.%20%3Ci%3EOncogene%3C%5C%2Fi%3E%2C%201%26%23x2013%3B14.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41388-021-01799-1%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1038%5C%2Fs41388-021-01799-1%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6807162%26amp%3Bitem_key%3DNHFQED8T%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Targeting%20protein%20lysine%20methyltransferase%20G9A%20impairs%20self-renewal%20of%20chronic%20myelogenous%20leukemia%20stem%20cells%20via%20upregulation%20of%20SOX6%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Min%22%2C%22lastName%22%3A%22Zhou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiuli%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chang%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Danian%22%2C%22lastName%22%3A%22Nie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shuyi%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Peilong%22%2C%22lastName%22%3A%22Lai%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yanli%22%2C%22lastName%22%3A%22Jin%22%7D%5D%2C%22abstractNote%22%3A%22The%20application%20of%20tyrosine%20kinase%20inhibitors%20%28TKIs%29%20in%20clinic%20has%20revolutionized%20chronic%20myelogenous%20leukemia%20%28CML%29%20treatment%2C%20but%20fails%20to%20eliminate%20leukemia%20stem%20cells%20%28LSCs%29%2C%20which%20are%20considered%20as%20roots%20of%20drug%20resistance%20and%20disease%20relapse.%20Thus%2C%20eradication%20of%20LSCs%20may%20be%20a%20promising%20strategy%20for%20curing%20CML.%20In%20this%20study%2C%20we%20found%20that%20protein%20lysine%20methyltransferase%20G9A%20was%20overexpressed%20in%20CML%20LSCs.%20The%20upregulation%20of%20G9A%20by%20BCR-ABL%20was%20independent%20on%20its%20tyrosine%20kinase%20activity.%20Knockdown%20of%20G9A%20by%20shRNAs%20or%20pharmacological%20inhibition%20of%20G9A%20by%20UNC0642%20significantly%20suppressed%20survival%20and%20impaired%20self-renewal%20capacity%20of%20CML%20LSCs.%20Inhibition%20of%20G9a%20eradicated%20LSCs%20in%20CML%20mice%20driven%20by%20BCR-ABL%20gene%20and%20dramatically%20prolonged%20survival%20of%20the%20mice.%20Ex%20vivo%20treatment%20with%20G9A%20inhibitor%20inhibited%20long-term%20engraftment%20of%20CML%20CD34%2B%20cells%20in%20immunodeficient%20mice.%20Mechanically%2C%20tumor%20suppressor%20SOX6%20was%20identified%20as%20a%20direct%20target%20of%20G9A%20in%20CML%20LSCs%20by%20RNA-seq%20analysis.%20Silencing%20Sox6%20at%20least%20partially%20rescued%20G9a%20knockdown-mediated%20LSCs%20elimination%20in%20vivo.%20Our%20findings%20improve%20the%20understanding%20of%20LSC%20regulation%20network%20and%20validate%20G9A%20as%20a%20therapeutic%20target%20in%20CML%20LSCs.%20Targeting%20G9A%20may%20be%20considered%20as%20an%20additional%20strategy%20for%20the%20treatment%20of%20patients%20with%20CML.%22%2C%22date%22%3A%222021-04-30%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1038%5C%2Fs41388-021-01799-1%22%2C%22ISSN%22%3A%221476-5594%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fwww.nature.com%5C%2Farticles%5C%2Fs41388-021-01799-1%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-04-30T18%3A31%3A48Z%22%7D%7D%5D%7D
Zhou, M., Zhang, X., Liu, C., Nie, D., Li, S., Lai, P., & Jin, Y. (2021). Targeting protein lysine methyltransferase G9A impairs self-renewal of chronic myelogenous leukemia stem cells via upregulation of SOX6. Oncogene, 1–14. https://doi.org/10.1038/s41388-021-01799-1 Cite